Fenimore Christopher R.
Reporting owner on Forms 3, 4 and 5, CIK 1697422.
Fenimore Christopher R. reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-04.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| REGN · REGENERON PHARMACEUTICALS, INC.CIK 872589 | officer (EVP Finance CFO) | 1 | 2026-11-04 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-02 | M exercised | +6,000 | $381.92 | 25,984 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-02 | F withheld for tax | -4,243 | $950.5 | 21,741 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock | 2026-11-02 | G gifted | -15 | $0 | 21,726 | Form 4 |
| REGN · REGENERON PHARMACEUTICALS, …Common Stock, holding | 1,576 | Form 4 | ||||
| REGN · REGENERON PHARMACEUTICALS, …Common Stock, holding | 1,897 | Form 4 | ||||
| REGN · REGENERON PHARMACEUTICALS, …Common Stock, holding | 25 | Form 4 | ||||
| REGN · REGENERON PHARMACEUTICALS, …Common Stock, holding | 25 | Form 4 | ||||
| REGN · REGENERON PHARMACEUTICALS, …Non-Qualified Stock Option (right to bu…, derivative | 2026-11-02 | M exercised | -6,000 | $0 | 0 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001697422-26-000004 | REGENERON PHARMACEUTICALS, INC. | 2026-11-04 |